FIELD: medicine.
SUBSTANCE: gel eye drops include dexamethasone sodium phosphate, a hyaluronic acid source, histidine hydrochloride monohydrate, boric acid, sodium tetraborate, polyethylene glycol, disodium edetate, potassium chloride, sodium chloride and water. The ingredients are used in the declared amounts.
EFFECT: use of the invention allows to effectively treat chronic and allergic inflammatory eye diseases of different severity without side effects and allergies.
10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| EYE GEL DROPS FOR TREATMENT OF INFLAMMATORY, VIRUS, BACTERIAL, ALLERGIC, METABOLIC, TRAUMATIC DISEASES | 2017 |
|
RU2688687C1 |
| EYE DROPS FOR DRY EYE SYNDROME | 2011 |
|
RU2459615C1 |
| EYE GEL DROPS FOR TREATING ACUTE AND CHRONIC INFLAMMATORY EYE DISEASES CAUSED BY VIRAL, BACTERIAL, ALLERGIC, METABOLIC OR TRAUMATIC FACTORS | 2018 |
|
RU2692087C1 |
| OPHTHALMIC COMPOSITION FOR TREATMENT OF CONJUNCTIVITES, BLEPARITIS AND MARGINAL CORNEAL ULCERS IN TOPICAL APPLICATION | 2016 |
|
RU2633055C1 |
| THERAPEUTIC AGENT FOR TREATING ALLERGIC AND VIRAL OCULAR DISEASES IN FORM OF GEL OR GEL-LIKE DROPS | 2015 |
|
RU2595244C1 |
| GEL DROPS FOR TREATING INFLAMMATORY EYE DISEASES, INCLUDING INFECTIOUS AND SUSTAINABLE TO ANTIBIOTICS DISEASES | 2017 |
|
RU2669768C1 |
| GEL-LIKE ARTIFICIAL TEARS WITH ANTISEPTIC AND REPARATIVE ACTION | 2018 |
|
RU2679319C1 |
| OPHTHALMIC GEL COMPOSITION FOR TREATING CONJUNCTIVITIS, BLEPHARITIS, KERATITIS CORNEAL EROSION ASSOCIATED WITH INFLAMMATORY EYE DISEASES OF NON-INFECTIOUS OR POST-INFECTIOUS ETIOLOGY AND ALLERGIC LESIONS OF OCULAR SURFACE | 2014 |
|
RU2582284C1 |
| GEL PHARMACEUTICAL COMPOSITION FOR BLEPHARITIS TREATMENT | 2016 |
|
RU2633054C1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF EYE DROPS FOR PREVENTING AND TREATING ALLERGIC EYE DISEASES | 2013 |
|
RU2549472C1 |
